HKSE - Delayed Quote HKD
Biosino Bio-Technology and Science Incorporation (8247.HK)
0.610
-0.010
(-1.61%)
At close: May 2 at 3:09:20 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
289,073
289,073
373,071
348,225
325,256
Cost of Revenue
161,708
161,708
226,794
204,633
214,695
Gross Profit
127,365
127,365
146,277
143,592
110,561
Operating Expense
145,352
145,352
123,642
128,329
119,355
Operating Income
-17,987
-17,987
22,635
15,263
-8,794
Net Non Operating Interest Income Expense
-6,072
-6,072
-6,482
-10,346
-412
Pretax Income
-17,613
-17,613
18,516
6,407
2,155
Tax Provision
1,628
1,628
4,314
3,247
2,861
Net Income Common Stockholders
-11,648
-11,648
8,106
-1,140
2,718
Diluted NI Available to Com Stockholders
-11,648
-11,648
8,106
-1,140
2,718
Basic EPS
-0.08
--
0.06
-0.01
0.02
Diluted EPS
-0.08
--
0.06
-0.01
0.02
Basic Average Shares
144,707.176
--
144,707.176
144,707.176
144,707.176
Diluted Average Shares
144,707.176
--
144,707.176
144,707.176
144,707.176
Total Expenses
307,060
307,060
350,436
332,962
334,050
Net Income from Continuing & Discontinued Operation
-11,648
-11,648
8,106
-1,140
2,718
Normalized Income
-11,114
-11,114
8,255.380
-1,043.250
-4,195.500
Interest Income
326
326
335
219
10,908
Interest Expense
6,398
6,398
6,817
10,565
11,320
Net Interest Income
-6,072
-6,072
-6,482
-10,346
-412
EBIT
-11,215
-11,215
25,333
16,972
13,475
EBITDA
9,142
9,142
49,662
44,900
38,768
Reconciled Cost of Revenue
161,708
161,708
226,794
204,633
214,695
Reconciled Depreciation
20,357
20,357
24,329
27,928
25,293
Net Income from Continuing Operation Net Minority Interest
-11,648
-11,648
8,106
-1,140
2,718
Total Unusual Items Excluding Goodwill
-712
-712
-194
-129
9,218
Total Unusual Items
-712
-712
-194
-129
9,218
Normalized EBITDA
9,854
9,854
49,856
45,029
29,550
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-178
-178
-44.620
-32.250
2,304.500
12/31/2020 - 2/27/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade